Teacher Retirement System of Texas bought a new stake in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 130,266 shares of the company's stock, valued at approximately $376,000. Teacher Retirement System of Texas owned 0.12% of Definitive Healthcare at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of DH. Bank of New York Mellon Corp increased its stake in Definitive Healthcare by 35.9% in the 4th quarter. Bank of New York Mellon Corp now owns 229,143 shares of the company's stock valued at $942,000 after buying an additional 60,559 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Definitive Healthcare by 28.0% during the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 146,623 shares of the company's stock worth $603,000 after purchasing an additional 32,071 shares in the last quarter. Intech Investment Management LLC boosted its position in shares of Definitive Healthcare by 166.1% during the 4th quarter. Intech Investment Management LLC now owns 32,979 shares of the company's stock worth $136,000 after purchasing an additional 20,586 shares in the last quarter. Quantbot Technologies LP boosted its position in shares of Definitive Healthcare by 5,305.5% during the 4th quarter. Quantbot Technologies LP now owns 17,730 shares of the company's stock worth $73,000 after purchasing an additional 17,402 shares in the last quarter. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of Definitive Healthcare during the 4th quarter worth $54,000. 98.67% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
DH has been the topic of several recent research reports. BTIG Research lowered shares of Definitive Healthcare from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. The Goldman Sachs Group boosted their price objective on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a research report on Monday, May 12th. Finally, Wall Street Zen upgraded shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, June 21st. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $5.10.
View Our Latest Stock Analysis on Definitive Healthcare
Definitive Healthcare Stock Performance
DH stock traded up $0.15 during mid-day trading on Monday, reaching $3.99. The company had a trading volume of 397,084 shares, compared to its average volume of 809,305. The company has a quick ratio of 1.75, a current ratio of 1.75 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $593.07 million, a P/E ratio of -0.91, a P/E/G ratio of 6.46 and a beta of 1.64. Definitive Healthcare Corp. has a one year low of $2.15 and a one year high of $6.16. The stock's 50-day simple moving average is $3.68 and its two-hundred day simple moving average is $3.63.
Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. The company had revenue of $59.19 million for the quarter, compared to analyst estimates of $56.20 million. Definitive Healthcare had a positive return on equity of 3.69% and a negative net margin of 206.05%. The company's quarterly revenue was down 6.8% compared to the same quarter last year. During the same period last year, the company earned $0.08 earnings per share. Research analysts anticipate that Definitive Healthcare Corp. will post 0.16 EPS for the current year.
Definitive Healthcare Company Profile
(
Free Report)
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Read More

Before you consider Definitive Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.
While Definitive Healthcare currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.